Insmed (INSM) PT Lowered to $162 at Evercore ISI
Evercore ISI analyst Gavin Clark-Gartner lowered the price target on Insmed (NASDAQ: INSM) to $162.00 (from $208.00) while maintaining a Outperform rating.
Evercore ISI analyst Gavin Clark-Gartner lowered the price target on Insmed (NASDAQ: INSM) to $162.00 (from $208.00) while maintaining a Outperform rating.